Lack of shedding of the RIX4414 live attenuated rotavirus vaccine administered to adult volunteers
暂无分享,去创建一个
C. Hart | F. McArdle | W. Dove | R. Rustom | L. Zibrik | M. Jackson
[1] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.
[2] N. Cunliffe,et al. A critical time for rotavirus vaccines: a review , 2005, Expert review of vaccines.
[3] T. Vesikari,et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. , 2004, Vaccine.
[4] J. Preiksaitis,et al. Increased detection of rotavirus using a real time reverse transcription‐polymerase chain reaction (RT‐PCR) assay in stool specimens from children with diarrhea , 2004, Journal of medical virology.
[5] D. Bernstein,et al. Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12. , 1998, Vaccine.
[6] A. Kapikian,et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. , 1997, The New England journal of medicine.
[7] D. Bernstein,et al. Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. , 1986, The Journal of infectious diseases.
[8] A. Kapikian,et al. Isolation of human rotavirus subgroups 1 and 2 in cell culture , 1982, Journal of clinical microbiology.